Hanna Saskia Menold
Papers
1
Total Citations
10
H-Index
1
About
Dr. Hanna Saskia Menold is a leading urologic oncology researcher whose work is redefining surgical standards for kidney cancer. Her primary research focuses on comparative effectiveness in nephron-sparing surgery, with a specific emphasis on patient-reported outcomes and quality-of-life metrics. Dr. Menold is best known for her pivotal role in the ROBOtic-assisted versus Conventional Open Partial Nephrectomy (ROBOCOP) II trial, a landmark randomized study that directly compared robot-assisted partial nephrectomy (RAPN) to open partial nephrectomy (OPN). Her most cited paper, the 2024 "Quality‐of‐life outcomes of the ROBOCOP II trial," provides the first robust, randomized evidence on how these surgical approaches impact patients’ daily lives, addressing a critical gap in the literature. With 10 citations already, this work is rapidly shaping clinical guidelines. Dr. Menold’s contributions are vital for surgeons and patients alike, offering data-driven clarity on recovery and well-being. Her dedication to rigorous, patient-centered research ensures that surgical innovation is measured not just by technical success, but by the real-world experiences of those she serves.
Research Focus
Key Achievements
Top Papers
- 1